Epifloxin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Epifloxin

Epifloxin is a synthetic, prescription-only antibiotic used to combat infections caused by susceptible bacteria. Its core purpose is to achieve the definitive bacterial elimination required to resolve an infection.

Property Description
Active ingredient Levofloxacin
Form Oral tablets, Intravenous solution
Pharmacological class Fluoroquinolone Antibiotic
Common purpose Systemic bacterial elimination
Origin Synthetic, Single-isomer

What Type of Medicine is Epifloxin and What is Its Origin?

Epifloxin is classified as a third-generation fluoroquinolone antibiotic, which is a powerful class of broad-spectrum antibacterial agents. This places Epifloxin within the family of quinolone antibiotics, representing a modern iteration often referred to as a respiratory fluoroquinolone. Its active component is Levofloxacin, which is the purified S-(-)-isomer of the older compound, ofloxacin. As a synthetic fluoroquinolone, it is utilized in the treatment of various bacterial infections.


Composition, Forms, and General Purpose

The active core of the medicine is Levofloxacin, a single-ingredient compound combined with inert, pharmaceutically necessary excipients. Epifloxin is typically supplied in multiple high-level dosage forms, including solid oral tablets and a liquid intravenous solution for direct parenteral administration. The availability across both the oral and intravenous routes allows for flexible patient management when systemic anti-infective treatment is necessary. The general therapeutic goal of Epifloxin is to achieve bactericidal elimination, as Levofloxacin is a concentration-dependent antibacterial agent.


How Epifloxin Differs from Older Antibiotics

Epifloxin's composition and design distinguish it from older treatments. By utilizing only the highly purified, active S-(-)-enantiomer of its predecessor, the product achieves a targeted mechanism of action with greater chemical specificity. This focus on a single, active isomer, rather than a racemic mixture, allows the drug’s activity to be concentrated on rapidly disrupting the pathogens’ ability to reproduce and survive, thereby providing a predictable and potent anti-infective treatment.

Regulatory References

  1. Levofloxacin StatPearls Reference

What side effects are possible with Epifloxin?

Possible Side Effects and Safety Information

This section outlines the officially documented adverse effects and safety characteristics of Epifloxin (Levofloxacin), based strictly on government regulatory documents.


Official Adverse Reactions and Frequency

Adverse reactions are classified by frequency as defined in regulatory documentation:

Classification Examples of Documented Effects
Common Nausea, Headache, Diarrhea, Insomnia, Dizziness
Uncommon Rash, Arthralgia (joint pain), Anxiety, Tremor, Abdominal pain
Rare Convulsion, Tendon rupture, Acute renal failure, Hypoglycaemia
Not Known Aortic dissection/aneurysm, Hypoglycaemic coma, Severe bullous skin reactions

Serious Safety Considerations

The official labeling highlights several serious and potentially irreversible adverse reactions. These include risks of Tendinitis and Tendon Rupture, which may occur early or months after stopping treatment, and Peripheral Neuropathy (nerve damage). Other serious risks documented in regulatory sources include severe Hepatotoxicity (liver injury), Aortic Aneurysm and Dissection, QT interval prolongation, and neuropsychiatric effects such as Suicidal Thoughts and Convulsions.

Safety Constraints and Special Populations

Regulatory documents outline specific limitations and safety notes:

  • Contraindications: Epifloxin is generally contraindicated in patients with a history of tendon disorders related to fluoroquinolones, epilepsy, or known hypersensitivity.
  • Pediatric Population: Use is generally contraindicated in children and growing adolescents, with few exceptions.
  • Discontinuation: The medication must be discontinued immediately upon the first sign of tendon pain, peripheral neuropathy symptoms, or signs of severe allergic reactions (e.g., rash).

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes the clinical presentation of an acute Epifloxin overdose as primarily involving the central nervous system (CNS) and the gastrointestinal system. Documented signs may include nausea, vomiting, confusion, and dizziness. Severe, high-dose overdose can lead to more serious manifestations such as convulsions, as well as potential effects on the heart, including prolongation of the QT interval on an electrocardiogram (ECG).

Immediate medical help is required for any suspected overdose. Emergency services should be contacted, or the patient should be taken to an emergency department or Poison Control Center immediately.

Management of an overdose is symptomatic and supportive, as there is no specific antidote available. Regulatory documents state that supportive measures include observing the patient closely. Based on the amount and time since ingestion, activated charcoal may be considered in a healthcare setting to help reduce the drug's absorption. Given the potential for serious cardiac effects, continuous ECG monitoring is typically necessary.

Due to the risk of severe CNS and cardiovascular toxicity, the official documentation mandates urgent medical intervention to manage the symptoms and ensure respiratory and cardiac stability.

Therapeutic Uses of Epifloxin

What Epifloxin treats: main uses and benefits

Epifloxin is applied across domains where additional symptomatic support is needed to address symptoms that create noticeable physiological strain. Its use is relevant in contexts involving heightened systemic burden.


Therapeutic Scope and Benefits

Epifloxin is commonly used across conditions presenting with acute episodes or conditions marked by increased physiological stress, which include infections like pneumonia, acute exacerbations of chronic bronchitis, complicated urinary tract infections (UTI), acute pyelonephritis (kidney infection), chronic bacterial prostatitis, and complicated skin and soft tissue infections (SSSI). In specific, high-risk scenarios, it is relevant for supportive management following exposure to conditions like inhalational anthrax.

The medication is relevant for easing symptoms related to physical discomfort like difficulty breathing, persistent cough, painful urination, and localized swelling. It contributes to easing the overall symptom load and supports patients during difficult episodes by easing distress.

“The medication assists with maintaining functional stability and helps improve day-to-day comfort during symptomatic periods.”


Quick Fact

Quick Fact: Relief for Symptoms related to systemic imbalance

Epifloxin may assist with reducing manifestations of symptoms associated with acute or episodic changes like fever and severe breathing difficulty. It contributes to improved comfort during periods of heightened symptoms by supporting the process of bacterial elimination.

Eligibility and Restrictions for Use

Who can and cannot use Epifloxin?

Eligibility for Epifloxin (Levofloxacin) is determined by official regulatory criteria, including age, physiological status, and underlying health conditions.

Contraindicated Populations

The medicine is formally contraindicated and must not be used by:

  • Patients with hypersensitivity to Levofloxacin or any other quinolone antibiotic.
  • Individuals with a history of tendon disorders related to previous fluoroquinolone use.
  • Patients with epilepsy.
  • Pregnant women and breastfeeding women (as cited by multiple regulatory authorities).
  • Children and growing adolescents in most regions, except for restricted indications.

Age and Condition-Based Eligibility

Population/Condition Eligibility Status (Regulatory)
Adults (18 years and older) Primary eligible population.
Pediatric Patients (6 months) Restricted use for specific life-threatening infections only (e.g., Inhalational Anthrax, Plague).
Renal Impairment (CrCl < 50 mL/min) Use requires mandatory dose adjustment.
Older Patients (60 years) Classified as an increased-risk population for tendon rupture.
Myasthenia Gravis Use should be avoided (due to risk of exacerbating muscle weakness).

These official rules strictly define the scope of use, establishing absolute exclusions for contraindicated groups and conditional eligibility for populations with certain age limits or organ function challenges.

What should I know about interactions with other medicines?

Epifloxin Interactions with Other Medicines and Products

Epifloxin's interaction profile involves substances that modify its absorption, alter its clearance, or reinforce specific pharmacodynamic risks, as documented in official regulatory sources.

Documented Interaction Patterns

Interaction Type Interacting Substances/Class Official Regulatory Statement
Reduced Absorption Multivalent Cation-Containing Products (e.g., Antacids, Iron/Zinc salts, Sucralfate) Oral absorption is significantly decreased (chelation), requiring a minimum 2-hour separation of doses.
Altered Clearance Probenecid, Cimetidine These agents increase Epifloxin plasma concentrations by blocking renal tubular secretion.
Risk Reinforcement Corticosteroids, NSAIDs/Fenbufen Co-administration increases the documented risk of tendinopathy (Corticosteroids) and lowering the cerebral seizure threshold (NSAIDs).
Drug Exposure Change Ciclosporin (Cyclosporine) Epifloxin officially increases the half-life and plasma exposure of this medicine by 33%.

Official Regulatory Classifications

Use of Epifloxin with other medicines known to prolong the QT interval is subject to restrictions due to the risk of additive cardiac effects. Furthermore, interactions with Warfarin and Antidiabetic Agents (Insulin, oral agents) are documented and may require procedural monitoring, as these combinations can alter the effects of the co-administered medicines.

Mechanism of Action

Epifloxin (Levofloxacin) is a bactericidal agent that functions by interfering with the core enzymatic machinery responsible for maintaining the bacterial genome, leading directly to pathogen death.

The drug's action involves the highly specific inhibition of two essential bacterial enzymes: DNA gyrase (Type II Topoisomerase II) and topoisomerase IV. These enzymes manage DNA supercoiling and chromosome separation, respectively. By binding to these targets, Epifloxin stabilizes a toxic cleavable complex, which traps the enzyme when it has cleaved the DNA strands, preventing their re-sealing. This blockade initiates a lethal mechanistic cascade where irreparable double-stranded DNA breaks accumulate throughout the bacterial genome. The resulting overwhelming damage prevents the cell from performing vital functions, leading to an unavoidable process of cell death. The physiological effect is concentration-dependent killing, resulting in the systemic elimination of susceptible pathogens.

This mechanism is constrained by bacterial defenses. Mutations in the QRDR of target enzymes reduce binding affinity, while the activity of bacterial efflux pumps actively transports the drug out of the cell.

Dosage and Administration Information

Epifloxin (a fluoroquinolone antibiotic) must be used exactly as prescribed by your healthcare provider. The dosage and duration of treatment will vary significantly depending on the type and severity of the bacterial infection being treated. It is crucial to complete the entire course of therapy, even if symptoms improve, to ensure the infection is fully eradicated and to minimize the risk of developing antibiotic resistance.

Administration Instructions

Formulation Key Instructions
Oral Tablets Can generally be taken with or without food. However, do not take the tablet or oral solution within two hours of taking antacids (containing magnesium or aluminum), sucralfate, or products containing metal cations (e.g., iron or zinc supplements), as these can significantly reduce the medicine’s absorption.
Ophthalmic Drops Wash hands thoroughly before use. Do not touch the dropper tip to your eye or any other surface to prevent contamination. If you wear contact lenses, remove them before applying the drops and wait at least 15 minutes before reinserting them. Close the eye gently for 1-2 minutes after application to ensure proper absorption.
Intravenous (IV) Infusion The injection must be administered slowly over 60 to 90 minutes; rapid infusion or bolus injection must be avoided due to the increased risk of hypotension (low blood pressure). This is typically performed by a healthcare professional in a clinical setting.

Important Considerations

Never use this medication for viral infections, such as a common cold or flu. Due to the risk of serious side effects, including tendinitis, tendon rupture, and peripheral neuropathy, Epifloxin (and other fluoroquinolones) should be reserved for use in patients with certain uncomplicated infections only when no other treatment options are available. If you experience pain, swelling, or inflammation in a tendon, or any new symptoms of nerve pain, discontinue use immediately and contact your doctor.

Recent Clinical Evidence

Epifloxin: Recent Clinical Evidence

The research evidence for Epifloxin, whose active ingredient is Levofloxacin, primarily focuses on the findings from Randomized Controlled Trials (RCTs). These trials are designed to evaluate treatment patterns across several types of bacterial infection, strictly maintaining a neutral, non-promotional tone when summarizing research.


Evidence for Acute Infections

For Community-Acquired Pneumonia (CAP), RCTs involving adults monitored patient outcomes by measuring clinical success endpoints and assessing the bacteriological eradication of the pathogen. Trials reported patterns related to the measurement of these endpoints in short-term follow-up periods. Similar RCTs were conducted for Complicated Urinary Tract Infections (cUTI), including pyelonephritis, where studies documented patterns related to pathogen clearance and clinical stability. Research for both conditions is continuously monitored due to the challenge of changing bacterial resistance patterns globally.


Evidence in Specific Contexts

Epifloxin has also been evaluated for Complicated Skin and Soft Tissue Infections (cSSSI) and for prolonged use in Chronic Bacterial Prostatitis. For cSSSI, reported patterns related to success endpoints are dependent on the specific type of bacteria causing the infection. Prostatitis studies involved a longer treatment course (around 28 days), though these trials often utilized relatively small patient numbers.

For high-risk situations like Inhalational Anthrax Post-Exposure Prophylaxis, the direct demonstration of benefit in humans relies on extrapolation from non-clinical animal efficacy studies (which monitored survival) and human Pharmacokinetic (PK) studies.


Research Gaps and Patient Groups

The majority of research focuses on short-term symptom changes, meaning that long-term outcomes and the durability of the initial response are not fully established. Evidence for Pediatric (children and adolescents) populations is narrow and primarily involves PK Analysis to examine the drug's concentration, rather than broad efficacy for common infections. Findings related to patients with complex underlying health issues are often uncertain or less detailed.

Key Studies & References

  1. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis

Frequently Asked Questions (FAQ)

Common questions about Epifloxin (FAQ)


Q: Do you have to take Epifloxin every day?

A: Official regulatory documents indicate that dosing regimens for Epifloxin (Levofloxacin) are generally described as once every 24 hours for the majority of approved indications in adults. However, the exact frequency and duration are determined by the healthcare provider based on the specific infection being treated.


Q: Are there any common over-the-counter medicines that interact with Epifloxin?

A: Yes, official product information explicitly identifies products that contain multivalent cations as having an interaction risk. These are often found in common over-the-counter products like antacids (containing magnesium or aluminum) or supplements (containing iron or zinc). Regulatory documents state that when taking the oral form of Epifloxin, these products require a dosing separation of at least two hours to limit the possibility of reduced absorption.


Q: I heard Epifloxin can't be taken with certain supplements—which ones?

A: Regulatory warnings specifically caution against taking oral Epifloxin within two hours of supplements that contain metal cations, such as iron or zinc supplements. This separation is described as necessary because these multivalent cations may limit how much of the medicine the body takes up.


Q: Is Epifloxin safe for older adults or the elderly population?

A: Official labeling classifies patients who are 60 years of age and older as an increased-risk population for certain serious side effects. Specifically, they have a higher risk of developing tendinitis and tendon rupture compared to younger patients, according to regulatory warnings.


Q: Is Epifloxin considered a long-term treatment option?

A: Levofloxacin is indicated for a range of treatment durations, typically 5 to 14 days for most acute infections. However, regulatory documents describe that certain specific indications, such as post-exposure prophylaxis for Anthrax, require a longer course of treatment that can last up to 60 days.


Q: Does Epifloxin have a black box warning from the FDA?

A: Yes. The FDA labeling for Levofloxacin contains a Boxed Warning (the agency's strongest precaution) that alerts users to the risk of serious and potentially irreversible adverse reactions. These reactions include tendinitis and tendon rupture, peripheral neuropathy (nerve damage), and various Central Nervous System (CNS) effects.


Q: Is Epifloxin generally well-tolerated?

A: Official data from clinical trials reported that the most common adverse reactions occurred in 3% or more of patients. These commonly reported effects include conditions such as nausea, headache, diarrhea, insomnia, and dizziness. These figures describe the frequency with which these effects were reported.


Q: How does Epifloxin compare to other similar medicines?

A: Epifloxin is officially classified as a fluoroquinolone antibacterial agent, which represents a specific class of broad-spectrum antibiotics. The medicine is a single-isomer compound designed to disrupt the life cycle of bacteria by inhibiting two critical bacterial enzymes, DNA gyrase and topoisomerase IV.


Q: Does Epifloxin interact with alcohol?

A: The drug's official labeling does not include a specific alcohol-interaction table, but it does contain warnings about Central Nervous System (CNS) effects, such as dizziness and potential seizures. Regulatory sources caution that these CNS effects may be worsened by the concurrent use of alcohol.


Q: How long does Epifloxin stay in your system after the last dose?

A: According to the official pharmacokinetic data, the mean terminal plasma elimination half-life of Levofloxacin is approximately 6 to 8 hours in healthy individuals. This indicates the rate at which the body eliminates the medicine.


Q: Can Epifloxin affect my ability to drive?

A: Official warnings caution that Epifloxin may impair a person's ability to perform tasks requiring mental alertness, such as driving or operating machinery. This is due to the potential for adverse effects, including dizziness and other Central Nervous System effects.


Q: Do you need special blood tests while taking Epifloxin?

A: Regulatory documents explicitly indicate that special laboratory monitoring is required when Epifloxin is used alongside certain other medicines. This includes close monitoring of laboratory values (like INR or blood glucose) if taking the drug with warfarin or antidiabetic agents (insulin or oral agents).


Q: Are there any foods I should strictly avoid while on Epifloxin?

A: Official administration instructions state that Levofloxacin oral tablets can generally be taken without regard to food. However, the oral solution should be taken either one hour before or two hours after a meal to ensure consistent absorption.


Q: What does the research say about Epifloxin's long-term safety?

A: The official Boxed Warning notes that some disabling and potentially irreversible serious adverse reactions may occur months after the medication is stopped, not just during treatment. These long-term safety concerns primarily relate to tendinitis and peripheral neuropathy.


Q: How long is a typical treatment course with Epifloxin?

A: The duration of treatment is highly variable, depending entirely on the type of infection being treated. Official dosage tables indicate that courses can range from a relatively short 5 days for some infections up to 60 days for specific high-risk prophylaxis treatments.


Q: Can Epifloxin affect male fertility?

A: Official non-clinical toxicology reports based on animal studies (rats) indicated that Levofloxacin did not affect fertility in those subjects. The regulatory documents note that these non-clinical findings may not be directly transferable to human risk.


Q: What are the common signs of an allergic reaction to Epifloxin?

A: Serious hypersensitivity reactions have been reported and may require immediate medical attention. Regulatory documents list signs such as swelling (of the face or throat), airway obstruction or trouble breathing, hives, and loss of consciousness.


Q: Does taking Epifloxin with food change how it works?

A: According to pharmacokinetic data, food has minimal effect on the absorption of the oral tablets. However, food may reduce the peak concentration of the drug in the body when the oral solution formulation is used.


Q: Are there specific symptoms that mean I should definitely contact a healthcare provider while on Epifloxin?

A: Yes. Official labeling states that the drug must be discontinued immediately and medical attention should be sought if the patient experiences signs of tendon pain or swelling, nerve pain (like tingling or numbness), severe allergic reactions, or severe neuropsychiatric effects (e.g., mood changes).


Q: Why is Epifloxin sometimes prescribed alongside other medications?

A: For specific, severe infections, the product labeling may recommend combination therapy. For example, official indications for treating Nosocomial Pneumonia sometimes call for Levofloxacin to be used in combination with an anti-pseudomonal beta-lactam agent.


Q: What are the guidelines for discontinuing Epifloxin?

A: There are two main guidelines: Regulatory guidelines state that the entire prescribed course of treatment should be completed to promote the eradication of the infection; conversely, the drug must be discontinued immediately upon the first sign of a serious adverse reaction, such as tendon pain or peripheral neuropathy.


Q: Can Epifloxin cause sensitivity to the sun?

A: Yes. Official warnings indicate that Levofloxacin is associated with photosensitivity or phototoxicity (an increased sensitivity to light). Patients are advised in official materials to avoid exposure to direct sunlight and artificial UV light while taking the medication.


Q: Are there any limitations on physical activity while taking Epifloxin?

A: The regulatory warning regarding tendinitis and tendon rupture highlights that patients should be cautious regarding activity that places stress on the tendons during treatment and the post-treatment period.

How should Epifloxin be stored and disposed of?

Storage Conditions

Epifloxin (Levofloxacin) tablets and oral solution must be stored at Controlled Room Temperature, which is 20 C to 25 C (68 F to 77 F), with excursions permitted to 30 C (86 F). The intravenous solution must not be frozen and should be kept in its protective carton to shield it from light until the time of use. Tablets must be protected from excessive moisture and kept in the original container.

Disposal Instructions

To discard unused or expired Epifloxin, the official regulatory guidance recommends utilizing a drug take-back program. If a take-back option is not readily available, the medicine must be disposed of in the household trash by mixing it with an undesirable substance, placing it in a sealed container, and then discarding it. The product must always be kept out of the reach of children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Epifloxin found in:

A-Z Index: